Medication interactions can pose a significant health risk. Identifying and understanding the degree of interaction and appropriate management allows for optimization of care while minimizing risk. In this interview, Glenn A. Hirsch, Barbara Wiggins, and Henry D. Huang discuss drug-drug interactions of concern in contemporary cardiovascular care.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Cardio-Oncology, Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Prevention, Pulmonary Hypertension and Venous Thromboembolism, Vascular Medicine, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Pulmonary Hypertension, Hypertension

Keywords: ACCELLite, Drug Interactions, Pharmacology, Anticoagulants, Arrhythmias, Cardiac, Metabolic Syndrome, Cardio-oncology, Cardiotoxicity, Dyslipidemias, Primary Prevention, Hypertension, Pulmonary

< Back to Listings